Valk P E, Dillon W P
Research Medicine and Radiation Biophysics Division, Lawrence Berkeley Laboratory, University of California, CA 94720.
AJNR Am J Neuroradiol. 1991 Jan;12(1):45-62.
The clinical, radiologic, and pathologic findings in radiation injury of the brain are reviewed. Late radiation injury is the major, dose-limiting complication of brain irradiation and occurs in two forms, focal and diffuse, which differ significantly in clinical and radiologic features. Focal and diffuse injuries both include a wide spectrum of abnormalities, from subclinical changes detectable only by MR imaging to overt brain necrosis. Asymptomatic focal edema is commonly seen on CT and MR following focal or large-volume irradiation. Focal necrosis has the CT and MR characteristics of a mass lesion, with clinical evidence of focal neurologic abnormality and raised intracranial pressure. Microscopically, the lesion shows characteristic vascular changes and white matter pathology ranging from demyelination to coagulative necrosis. Diffuse radiation injury is characterized by periventricular decrease in attenuation of CT and increased signal on proton-density and T2-weighted MR images. Most patients are asymptomatic. When clinical manifestations occur, impairment of mental function is the most prominent feature. Pathologic findings in focal and diffuse radiation necrosis are similar. Necrotizing leukoencephalopathy is the form of diffuse white matter injury that follows chemotherapy, with or without irradiation. Vascular disease is less prominent and the latent period is shorter than in diffuse radiation injury; radiologic findings and clinical manifestations are similar. Late radiation injury of large arteries is an occasional cause of postradiation cerebral injury, and cerebral atrophy and mineralizing microangiopathy are common radiologic findings of uncertain clinical significance. Functional imaging by positron emission tomography can differentiate recurrent tumor from focal radiation necrosis with positive and negative predictive values for tumor of 80-90%. Positron emission tomography of the blood-brain barrier, glucose metabolism, and blood flow, together with MR imaging, have demonstrated some of the pathophsiology of late radiation necrosis. Focal glucose hypometabolism on positron emissin tomography in irradiated patients may have prognostic significance for subsequent development of clinically evident radiation necrosis.
本文回顾了脑辐射损伤的临床、放射学及病理学表现。晚期辐射损伤是脑部放疗的主要剂量限制性并发症,有局灶性和弥漫性两种形式,其临床和放射学特征有显著差异。局灶性和弥漫性损伤均包含一系列广泛的异常表现,从仅通过磁共振成像(MR)检测到的亚临床改变到明显的脑坏死。在局灶性或大体积照射后的CT和MR检查中,常可见无症状的局灶性水肿。局灶性坏死在CT和MR上表现为占位性病变的特征,伴有局灶性神经功能异常和颅内压升高的临床证据。显微镜下,病变显示出特征性的血管变化和白质病理改变,范围从脱髓鞘到凝固性坏死。弥漫性辐射损伤的特征是CT上脑室周围密度减低,质子密度加权和T2加权MR图像上信号增强。大多数患者无症状。当出现临床表现时,精神功能损害是最突出的特征。局灶性和弥漫性辐射坏死的病理表现相似。坏死性白质脑病是化疗后出现的弥漫性白质损伤形式,可伴有或不伴有放疗。与弥漫性辐射损伤相比,血管疾病不那么突出,潜伏期更短;放射学表现和临床表现相似。大动脉的晚期辐射损伤是放疗后脑损伤的偶发原因,脑萎缩和矿化性微血管病是常见的放射学表现,其临床意义尚不确定。正电子发射断层扫描(PET)功能成像可区分复发性肿瘤和局灶性辐射坏死,对肿瘤的阳性和阴性预测值为80 - 90%。血脑屏障、葡萄糖代谢和血流的PET检查,结合MR成像,已揭示了晚期辐射坏死的一些病理生理学机制。放疗患者PET上的局灶性葡萄糖代谢减低可能对随后临床明显的辐射坏死的发生具有预后意义。